The 27th annual edition of this important, nationally recognized conference has just completed. PANAO is a place for healthcare professionals to share and learn about the results of clinical studies of new anticancer agents and current treatment strategies. National experts presenting at this conference will address these needs and share their knowledge and expert opinions. In addition, attendees will learn how to use pharmacogenomics and personalized medicine approaches to help select novel new therapies for patients.

The conference gives an up-to-date review of recently approved new and promising investigational agents in oncology and hematology and will also provide educational opportunities for hematology/oncology fellows, nurse practitioners, physician assistants, registered nurses, pharmacists, and clinical research coordinators. Topics will include combining ADC with immunotherapy, advances in KRAS inhibitors, advances in protein kinase inhibitors, novel therapies in lung cancers, advances in pancreatic cancers, and much more.

The conference is a continuing education (CME) activity for healthcare professionals specializing in oncology and hematology.